Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation - Are they inter-related?

Clinical Nephrology

Volumn 56, Issue 6, 2001, Pages

  Sebekova K ^a   Podracka L ^a   Heidland, A ^a   Schinzel, R ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Advanced glycation end products; Carboxy methyllysine; Chronic renal insufficiency; CRP; Dialysis; IL 6; Renal transplantation; TNF

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; CREATININE; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; PROTEIN EXPRESSION; RECEPTOR BINDING; REGRESSION ANALYSIS; SPECTROFLUOROMETRY; SUBSTITUTION THERAPY;

ADOLESCENT; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035213858     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients
2. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
3. Advanced protein glycosylation in diabetes and aging
4. The pathogenesis and consequences of AGE formation in uraemia and its treatment
5. ε-(carboxymethyl) lysine is increased in uremia
6. Toxicity of uremia-does it come of AGE?
7. Low-molecular but not high-molecular AGEs are removed by high-flux hemodialysis
8. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE peptides by renal proximal tubular cells
9. Effects of kidney or kidney pancreas transplantation on plasma pentosidine
10. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
11. Determinants of albumin concentration in hemodialysis patients
12. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging
13. Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity
14. Relevance of oxidative and carbonyl stress to long-term uremic complications
15. Accumulation of albumin-linked and free form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in pathophysiology of pentosidine
16. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA
17. Plasma advanced glycation end products in maintenance hemodialysis patients
18. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects
19. C-reactive protein as a marker of chronic inflammation in uremic patients
20. Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
21. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
22. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)-lysine in human tissues in diabetes and aging
23. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecula 1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism accelerated vasculopathy in diabetes
24. Cytokine induction in patients undergoing regular hemodiafiltration treatment
25. Cachectin/TNF and IL-1 induced by glucose-modified proteins. Role in normal tissue remodeling
26. Serum advanced glycosylation end products: A new class of uremic toxins
27. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors binding protein
28. C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients
29. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients